Lu-177-PSMA-617 radioligand therapy in mCRPC patients with a single functioning kidney

Nuklearmedizin 2019; 58(02): 194
DOI: 10.1055/s-0039-1683740

Poster

Theranostik

Georg Thieme Verlag KG Stuttgart · New York

J Zhang

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

HR Kulkarni

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

A Singh

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

C Schuchardt

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

K Niepsch

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

T Langbein

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka

,

RP Baum

¹Zentralklinik Bad Berka, THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Bad Berka